Publications

Selected Publications:

16. Stock JM, Romberger NT, McMillan RK, Chung JW, Wenner MM, Stocker SD, Farquhar WB, Burciu RG. Acute Hypernatremia Increases Functional Connectivity of NaCl Sensing Regions in the Human Brain: an fMRI Pilot Study. Auton Neurosci: Basic and Clin. doi: 10.1016/j.autneu.2024.103182.
15. Chung JW, Bower AE, Malik I, Martello JP, Knight CA, Jeka JJ, Burciu RG (2023). fMRI Changes during Multi-Limb Movements in Parkinson’s Disease. Front Hum Neurosci, doi: 10.3389/fnhum.2023.1248636. eCollection 2023.
14. Bower AE, Crisomia SJ, Chung JW, Martello JP, Burciu RG (2023). Free Water Imaging Unravels Unique Patterns of Longitudinal Structural Brain Changes in Parkinson’s Disease Subtypes. Front Neurol, doi: 10.3389/fneur.2023.1278065. eCollection 2023.
13. Chung JW, Bower AE*, Malik I, Martello JP, Knight CA, Jeka JJ, Burciu RG (2023). Imaging the Lower Limb Network in Parkinson’s Disease. Neuroimage Clin, doi: 10.1016/j.nicl.2023.103399.
12. Chung JW, Knight CA, Bower AE*, Martello JP, Jeka JJ, Burciu RG (2023). Rate Control Deficits during Pinch Grip and Ankle Dorsiflexion in Early-Stage Parkinson’s Disease. PLoS One, 18(3): e0282203. doi: 10.1371/journal.pone.0282203.
11. Quattrone A, Bianco MG, Antonini A, Vaillancourt DE, Seppi K, Ceravolo R, Strafella AP, Tedeschi G, Tessitore A, Cilia R, Morelli M, Nigro S, Vescio B, Arcuri PP, De Micco R, Cirillo M, Weis L, Fiorenzato E, Biundo R, Burciu RG, Krismer F, McFarland NR, Mueller C, Gizewski ER, Cosottini M, Del Prete E, Mazzucchi S, Quattrone A (2022). Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy Parkinsonism from Parkinson’s Disease. Mov Disord, 37(6): 1272-1281. doi: 10.1002/mds.28992.
10. Arpin DJ, Mitchell T, Archer DB, Burciu RG, Chu WT, Gao H, Guttuso T, Hess CW, Lai S, Malaty IA, McFarland NR, Pasternak O, Price CC, Shukla AW, Wu SS, Okun MS, Vaillancourt DE (2022). Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson’s Disease: A Placebo-Controlled Trial of Rasagiline. Mov Disord, 37(2):325-333. doi: 10.1002/mds.28838.
09. Quattrone A, Antonini A, Vaillancourt DE, Seppi K, Ceravolo R, Strafella AP, Morelli M, Nigro S, Vescio B, Bianco MG, Vasta R, Arcuri PP, Weis L, Fiorenzato E, Biundo R, Burciu RG, Krismer F, McFarland NR, Mueller C, Gizewski ER, Cosottini M, Del Prete E, Mazzucchi S, Quattrone A (2021). A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy from De Novo Parkinson’s Disease in Clinical Practice: An International Study. Mov Disord, 36(3): 681-689. doi: 10.1002/mds.28364.
08. Jia XZ, Zhao N, Dong HM, Sun JW, Barton M, Burciu RG, Carriere N, Cerasa A, Chen BY, Chen J, Coombes S, Defebvre L, Delmaire C, Dujardin K, Esposito F, Fan GG, Di Nardo F, Feng YX, Fling BW, Gilat SG, Gorges M, Ho SL, Horak FB, Hu X, Hu XF, Huang B, Huang PY, Jia ZJ, Jones C, Kassubek J, Krajcovicoya L, Kurani A, Li J, Li Q, Liu AP, Liu B, Liu H, Liu WG, Lopes R, Lou YT, Luo W, Madhyastha T, Mao NN, McAlonan G, McKeown MJ, Pang G, Quattrone A, Rektorova I, Sarica A, Shang HF, Shine JM, Shukla P, Slavicek T, Song XP, Tedeschi G, Tessitore A, Vaillancourt DE, Wang J, Wang J, Wang J, Wei LQ, Wu X, Xu XJ, Yan L, Yang J, Yang WQ, Yao NL, Zhang D, Zhang JQ, Zhang MM, Zhang L, Zhou L, Zhou CH, Yan CG, Zuo*, XN, Hallet M, Wu T, Zanf YF (2021). Small P Values May Not Yield Robust Findings: An Example Using REST-Meta-PD. Science Bulletin, 66: 2148-2152. doi: 10.1016/j.scib.2021.06.007.
07. Archer DB, Mitchell T, Burciu RG, Yang J, Salvatore N, Quatronne A, Quatronne A, Jeromin A, McFarland NR, Okun M, Vaillancourt DE (2020). Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism. Mov Disord, 35(8): 1388-1395. doi: 10.1002/mds.28060.
06. Nigro S, Antonini A, Vaillancourt DE, Klaus S, Ceravolo R, Strafella AP, Augimeri A, Quattrone A, Morelli M, Weis L, Fiorenzato E, Biundo R, Burciu RG, Krismer F, McFarland N, Mueller C, Gizewski ER, Cosottini M, Del Prete E, Mazzucchi S, Quattrone A (2020). Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study. Mov Disord, 35(6): 976-983. doi: 10.1002/mds.28007.
05. Archer DB, Bricker JT, Chu WT, Burciu RG, McCracken JL, Lai S, Coombes SA, Fang E, Barmpoutis A, Corcos DM, Kurani AS, Mitchell T, Black ML, Herschel E, Simuni T, Parrish TB, Comella C, Xie T, Seppi K, Bohnen NI, Müller MLT, Albin RG, Krismer F, Du G, Lewis MM, Huang X, Li H, Pasternak O, McFarland NR, Okun MS, Vaillancourt DE (2019). Development and Validation of the Automated Imaging Differentiation in Parkinsonism (AID-P): A Multi-Site Machine Learning Study. Lancet Digit Health, 1(5): e222-231. doi: 10.1016/s2589-7500(19)30105-0.
04. Yacoubi B, Casamento-Moran A, Burciu RG, Subramony SH, Vaillancourt DE, Christou EA (2020). Temporal Invariance in SCA6 is Related to Smaller Cerebellar Lobule VI and Greater Disease Severity. doi: 10.1523/JNEUROSCI.1532-19.2019. J Neurosci, 40(8): 1722-1731.
03. Yang J, Archer DB, Burciu RG, Müller MLT, Roy A, Ofori E, Bohnen NI, Albin RL, Vaillancourt DE (2019). Multimodal Dopaminergic and Free-Water Imaging in Parkinson’s Disease. Parkinsonism Relat Disord, 62: 10-15. doi: 10.1016/j.parkreldis.2019.01.007.
02. Burciu RG, Vaillancourt DE (2018). Imaging of Motor Cortex Physiology in Parkinson’s Disease. Mov Disord, 33(11): 1688-1699. doi: 10.1002/mds.102. 
01. Yang J, Burciu RG, Vaillancourt DE (2018). Longitudinal Progression Markers of Parkinson’s Disease: Current View on Structural Imaging. Curr Neurol Neurosci Rep, 18(12): 83. doi: 10.1007/s11910-018-0894-7.

Link to Full List of Publications (PubMed)